Amwill Healthcare IPO
- IPO Date05 Feb, 2025 to 07 Feb, 2025
- Listing Date12 Feb, 2025
- Face Value₹10 per share
- Issue Price₹105 to ₹111 per share
- Lot Size1200 Shares
- Minimum Investment₹1,33,200
- Listing AtBSE SME
- Total Issue Size54,03,600 Shares
(aggregating up to ₹59.98 Cr) - Fresh Issue44,03,600 Shares
(aggregating up to ₹48.88 Cr)
- Offer for Sale10,00,000 Shares
(aggregating up to ₹11.10 Cr) - Issue TypeBook Built Issue IPO
- Share holding pre issue1,56,00,000
- Shareholding post issue2,00,03,600
IPO Dates
Closing Date
07 Feb, 2025
Initiation of Refunds
11 Feb, 2025
Listing Date
12 Feb, 2025
05 Feb, 2025
Opening Date
10 Feb, 2025
Basis of Allotment
11 Feb, 2025
Credit of Shares
Amwill Healthcare Lot Size
Investors can bid for a minimum of 1200 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| S-HNI (Max) | - | - | - |
| Retail (Min) | 1 | 1200 | ₹1,33,200 |
| B-HNI (Min) | - | - | - |
| S-HNI (Min) | 2 | 2400 | ₹2,66,400 |
| Retail (Max) | 1 | 1200 | ₹1,33,200 |
Amwill Healthcare Promoter Holding
The Promoters of the Company are namely Anand Gandhi and Tarun Gandhi.
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 97% | - |
Amwill Healthcare COMPANY INFORMATION
Amwill Healthcare IPO is a book built issue of Rs 59.98 crores. The issue is a combination of fresh issue of 44.04 lakh shares aggregating to Rs 48.88 crores and offer for sale of 10.00 lakh shares aggregating to Rs 11.10 crores. Amwill Healthcare IPO opens for subscription on February 5, 2025 and closes on February 7, 2025. The allotment for the Amwill Healthcare IPO is expected to be finalized on Monday, February 10, 2025. Amwill Healthcare IPO will list on BSE SME with tentative listing date fixed as Wednesday, February 12, 2025. Amwill Healthcare IPO price band is set at ₹105 to ₹111 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,33,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,66,400. Unistone Capital Pvt Ltd is the book running lead manager of the Amwill Healthcare IPO, while Bigshare Services Pvt Ltd is the registrar for the issue.The market maker for Amwill Healthcare IPO is Globalworth Securities Limited. Refer to Amwill Healthcare IPO RHP for detailed information.
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
- Development of generic dermatological solutions and
- Formulating targeted solutions for dermatological issues.
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
Competitive Strength
- Extensive product portfolio supported by product formulation capabilities
- Provision of high-quality product development through tie-ups with contract manufacturers and prototype developers
- Well-experienced management team with proven project management and implementation skills
- Asset-light business model.
Amwill Health Care IPO
IPO Overview and Key Highlights
Amwill Health Care, a Bangalore-based company focused on health care solutions, is launching its Initial Public Offering (IPO). The IPO consists of a fresh issue of up to 44,03,600 equity shares and an Offer for Sale (OFS) of up to 10,00,000 equity shares, making the total offer size 54,03,600 equity shares. The proceeds from the IPO will be used for business expansion, working capital needs, and general corporate purposes. Shares will be listed on the SME Platform of BSE.
Key IPO Details
- Type of Issue: Book Built Issue
- Total Issue Size: 54,03,600 equity shares
- Face Value: ₹10 per share
- Offer Price: To be determined
- Offer Opens: February 5, 2025
- Offer Closes: February 7, 2025
- Listing Exchange: BSE SME
Company Overview
Founded in 2017, Amwill Health Care specializes in providing a range of health care solutions, including medical devices and services. The company is promoted by Anand Gandhi and Tarun Gandhi, who bring considerable expertise in health care management and innovation. The company has a strong market presence in Karnataka and aims to expand its reach nationwide.
Financial Overview
Amwill Health Care has demonstrated stable growth in revenue and profitability since its inception. The IPO proceeds will support the company’s efforts to enhance its infrastructure, increase its market presence, and strengthen its financial position.
Key Strengths of Amwill Health Care
- Innovative Health Care Solutions: Offers a diverse range of medical products and services.
- Experienced Promoters: Leadership with a solid background in health care and business operations.
- Expanding Market Presence: Plans for nationwide expansion with a focus on underserved regions.
IPO Pros and Cons
Pros
- Growing Health Care Industry: Positioned in a rapidly growing sector with increasing demand for quality health care.
- Proceeds Utilization: Funds aimed at expanding operations and improving service delivery.
- Reputable Brand: Recognized for innovative and reliable health care solutions.
Cons
- Market Dependency: Revenue influenced by the overall health care industry’s performance.
- Competitive Landscape: Faces competition from established health care providers and suppliers.
- Regulatory Challenges: Compliance with stringent health care regulations.
Risk Factors
Investors should consider the following risks before investing:
- Economic Sensitivity: Revenue can be affected by changes in health care spending.
- Operational Challenges: Managing expansion while maintaining quality.
- Regulatory Compliance: Adhering to health care and safety regulations.
Conclusion
The Amwill Health Care IPO offers an opportunity to invest in a growing health care provider with a strong presence in Karnataka and ambitious plans for national expansion. The company’s focus on innovation and experienced leadership positions it well for future growth. However, potential investors should carefully evaluate risks related to market dependency, competition, and regulatory compliance before making an investment decision.
FAQs About Amwill Healthcare Ipo
Amwill Healthcare IPO will open on 05 Feb, 2025 and close on 07 Feb, 2025. Investors must apply within this period to participate.
The Amwill Healthcare IPO price band is set between ₹105.00 and ₹111.00 per share. The minimum lot size is 1200, requiring an investment of at least ₹133200.00.
The Amwill Healthcare IPO shares are expected to be listed on 12 Feb, 2025, subject to regulatory approvals and final allotment.
You can track your Amwill Healthcare IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Amwill Healthcare IPO will be listed on major stock exchanges such as BSE, where you can trade shares once they are listed.